Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

In addition, the raw proteomics data are available in Supplementary Data 2.Top ten proteins in the protein coronae of RSV, HSV-1, and crude biological fluidsTop ten proteins RSV + HP HSV-1 + HP HP Beta-actin-like protein 2 [ACTBL_HUMAN]Ig gamma-1 chain C region [A0A087X079_HUMAN]Serum albumin [ALBU_HUMAN]Actin, cytoplasmic 1[ACTB_BOVIN]Complement C3 [CO3_HUMAN]Ig alpha-1 chain C region [IGHA1_HUMAN]Actin, alpha skeletal muscle [ACTS_BOVIN]Complement component 3 [A0A0F6QNP7_BOVIN]Serotransferrin [TRFE_HUMAN]Complement C4-B [CO4B_HUMAN]Ig gamma-3 chain C region (Fragment) [A0A075B6N8_HUMAN]Ig alpha-2 chain C region [IGHA2_HUMAN]Complement C4-A [CO4A_HUMAN]Envelope glycoprotein D [GD_HHV1F]Protein IGKV3-11 [A0A087WZW8_HUMAN]Complement C3 [CO3_HUMAN]Protein IGKV3-11 [A0A087WZW8_HUMAN]Ig lambda-3 chain C regions (Fragment) [A0A075B6L0_HUMAN]Complement component 3 [A0A0F6QNP7_BOVIN]Complement C4-B [CO4B_HUMAN]Ig lambda-1 chain C regions (Fragment) [A0A075B6K8_HUMAN]Tubulin alpha-1C chain [TBA1C_HUMAN]Complement C4-A [CO4A_HUMAN]Haptoglobin OS [HPT_HUMAN]Nucleoprotein [NCAP_HRSVA]Tegument protein UL47 [TEG5_HHV1F]Isoform 2 of Fibrinogen alpha chain [FIBA_HUMAN]Glyceraldehyde-3-phosphate dehydrogenase [G3P_HUMAN]Envelope glycoprotein E [GE_HHV1F]Hemopexin OS [HEMO_HUMAN] RSV + FBS HSV-1 + FBS FBS Actin, cytoplasmic 1 [ACTB_BOVIN]Chromatin assembly factor 1 subunit B [A5D9H4_BOVIN]Serum albumin [A0A140T897_BOVIN]Beta-actin-like protein 2 [ACTBL_HUMAN]PRPF8 protein [A7Z025_BOVIN]ALB protein [B0JYQ0_BOVIN]Actin, alpha skeletal muscle [ACTS_BOVIN]Angiotensinogen [ANGT_HUMAN]Alpha-2-HS-glycoprotein [FETUA_BOVIN]Tubulin alpha-1C chain [TBA1C_HUMAN]Thyroglobulin [F1MPH3_BOVIN]Serotransferrin [G3X6N3_BOVIN]Glyceraldehyde-3-phosphate dehydrogenase [G3P_HUMAN]Serglycin [SRGN_HUMAN]Serotransferrin [TRFE_BOVIN]Nucleoprotein [NCAP_HRSVA]Histone H2B type 1-N [H2B1N_BOVIN]Fetuin-B [FETUB_BOVIN]Phosphoprotein [PHOSP_HRSVA]Keratin, type II cytoskeletal [K2C6A_HUMAN]Protein AMBP [F1MMK9_BOVIN]Tubulin alpha-4A chain [TBA4A_BOVIN]Period circadian protein homolog 3 [A0A087WV69_HUMAN]Vitamin D-binding protein [VTDB_BOVIN]Heat shock 70 kDa protein 1A [HS71A_HUMAN]Uncharacterized protein [H9H2P7_MACMU]Vitamin D-binding protein [F1N5M2_BOVIN]Glyceraldehyde-3-phosphate dehydrogenase [I2CWU4_MACMU]Uncharacterized protein [F6WIY2_MACMU]Alpha-1B-glycoprotein [A1BG_BOVIN] RSV + BALF HSV-1 + BALF BALF Actin, alpha skeletal muscle [ACTS_BOVIN]Tyrosine-protein kinase receptor [F1MCM5_BOVIN]Serum albumin [ALBU_HUMAN]Actin, cytoplasmic 1 [ACTB_BOVIN]Chromatin assembly factor 1 subunit B [A5D9H4_BOVIN]Serotransferrin [TRFE_HUMAN]Beta-actin-like protein [ACTBL_HUMAN]PRPF8 protein [A7Z025_BOVIN]Ig alpha-1 chain C region [IGHA1_HUMAN]Phosphoprotein [PHOSP_HRSVA]Thyroglobulin [F1MPH3_BOVIN]Uteroglobin [UTER_HUMAN]Glyceraldehyde-3-phosphate dehydrogenase [G3P_HUMAN]XYLT2 protein (Fragment) [A4FV62_BOVIN]Lysozyme C [LYSC_HUMAN]Matrix protein [MATRX_HRSVA]Lactotransferrin (Fragment) [E7EQB2_HUMAN]Ig alpha-2 chain C [IGHA2_HUMAN]Nucleoprotein OS [NCAP_HRSVA]Serum amyloid P-component [SAMP_HUMAN]Protein IGKV3-11 [A0A087WZW8_HUMAN]Isoform 2 of Heat shock protein 75 kDa, mitochondrial [TRAP1_HUMAN]Angiotensinogen [ANGT_HUMAN]Antileukoproteinase [SLPI_HUMAN]Pulmonary surfactant-associated protein A2 [SFPA2_HUMAN]Ig lambda chain V-III region SH [LV301_HUMAN]Ig lambda-3 chain C regions (Fragment) [A0A075B6L0_HUMAN]Isoform 2 of 4F2 cell-surface antigen heavy chain [4F2_HUMAN]Platelet factor 4 [PLF4_HUMAN]Ig lambda-1 chain C regions (Fragment) [A0A075B6K8_HUMAN] RSV + MP RSV + jHP MP Actin, cytoplasmic 1 [ACTB_BOVIN]Apolipoprotein A-I [APOA1_HUMAN]Serum albumin (Fragment) [ALBU_MACMU]Actin, alpha skeletal muscle [ACTS_BOVIN]Serum albumin [ALBU_HUMAN]Uncharacterized protein [G7MT40_MACMU]Beta-actin-like protein 2 [ACTBL_HUMAN]Apolipoprotein A-II [APOA2_HUMAN]Uncharacterized protein [G7MJR4_MACMU]Phosphoprotein [PHOSP_HRSVA]Isoform Gamma-A of Fibrinogen gamma chain [FIBG_HUMAN]Transferrin OS [F7DHR8_MACMU]Tetraspanin (Fragment) [G7N5L6_MACMU]Fibrinogen beta chain [FIBB_HUMAN]Fibrinogen alpha chain [F6UZ60_MACMU]Serum albumin (Fragment) [ALBU_MACMU]Apolipoprotein B-100 [APOB_HUMAN]Putative uncharacterized protein [F6WR34_MACMU]Uncharacterized protein [G7MT40_MACMU]Fibrinogen alpha chain [FIBA_HUMAN]Uncharacterized protein [F6UZ87_MACMU]Matrix protein [MATRX_HRSVA]Actin, cytoplasmic 1 [ACTB_BOVIN]Haptoglobin isoform 2 preproprotein [H9Z8D4_MACMU]Glyceraldehyde-3-phosphate dehydrogenase [G3P_HUMAN]Beta-actin-like protein 2 [ACTBL_HUMAN]Uncharacterized protein [A0A1D5QT02_MACMU]Isoform 2 of 4F2 cell-surface antigen heavy chain [4F2_HUMAN]ALB protein [B0JYQ0_BOVIN]Hemoglobin subunit beta [HBB_MACMU]

Source: Rich and unique protein coronae for RSV and HSV-1. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Importantly, we show that HSV-1 catalyzes the aggregation of the amyloid β-peptide (Aβ42), a major constituent of amyloid plaques in Alzheimer’s disease, in vitro and in animal models.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The viral protein corona directs viral pathogenesis and amyloid aggregation

Study design awaiting verification · Nature Communications · 2019

Original publication title

The viral protein corona directs viral pathogenesis and amyloid aggregation

Kariem Ezzat; Maria Pernemalm; Sandra Pålsson; Thomas C. Roberts; Peter Järver; Aleksandra Dondalska; Burcu Bestas; Michal J. Sobkowiak; Bettina Levänen; Magnus Sköld; Elizabeth A. Thompson; Osama Saher; Otto K. Kari; Tatu Lajunen; Eva Sverremark Ekström; Caroline Nilsson; Yevheniia Ishchenko; Tarja Malm; Matthew J. A. Wood; Ultan F. Power; Sergej Masich; Anders Lindén; Johan K. Sandberg; Janne Lehtiö; Anna-Lena Spetz; Samir EL Andaloussi

© The Author(s) 2019

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Artificial nanoparticles accumulate a protein corona layer in biological fluids, which significantly influences their bioactivity. As nanosized obligate intracellular parasites, viruses share many biophysical properties with artificial nanoparticles in extracellular environments and here we show that respiratory syncytial virus (RSV) and herpes simplex virus type 1 (HSV-1) accumulate a rich and distinctive protein corona in different biological fluids. Moreover, we show that corona pre-coating differentially affects viral infectivity and immune cell activation. In addition, we demonstrate that viruses bind amyloidogenic peptides in their corona and catalyze amyloid formation via surface-assisted heterogeneous nucleation.

Importantly, we show that HSV-1 catalyzes the aggregation of the amyloid β-peptide (Aβ42), a major constituent of amyloid plaques in Alzheimer’s disease, in vitro and in animal models. Our results highlight the viral protein corona as an acquired structural layer that is critical for viral: host interactions and illustrate a mechanistic convergence between viral and amyloid pathologies.

The protein corona around artificial nanoparticles is known to influence activity and biological fate, the formation around viruses is less well understood. Here, the authors observe the formation of protein corona on viruses and study the effects this corona has on viral infectivity and on amyloid protein assembly.

Authors’ abstract

Artificial nanoparticles accumulate a protein corona layer in biological fluids, which significantly influences their bioactivity. As nanosized obligate intracellular parasites, viruses share many biophysical properties with artificial nanoparticles in extracellular environments and here we show that respiratory syncytial virus (RSV) and herpes simplex virus type 1 (HSV-1) accumulate a rich and distinctive protein corona in different biological fluids. Moreover, we show that corona pre-coating differentially affects viral infectivity and immune cell activation. In addition, we demonstrate that viruses bind amyloidogenic peptides in their corona and catalyze amyloid formation via surface-assisted heterogeneous nucleation.

Importantly, we show that HSV-1 catalyzes the aggregation of the amyloid β-peptide (Aβ42), a major constituent of amyloid plaques in Alzheimer’s disease, in vitro and in animal models. Our results highlight the viral protein corona as an acquired structural layer that is critical for viral: host interactions and illustrate a mechanistic convergence between viral and amyloid pathologies.

The protein corona around artificial nanoparticles is known to influence activity and biological fate, the formation around viruses is less well understood. Here, the authors observe the formation of protein corona on viruses and study the effects this corona has on viral infectivity and on amyloid protein assembly.

Publication and source details

Original title: The viral protein corona directs viral pathogenesis and amyloid aggregation

Kariem Ezzat; Maria Pernemalm; Sandra Pålsson; Thomas C. Roberts; Peter Järver; Aleksandra Dondalska; Burcu Bestas; Michal J. Sobkowiak; Bettina Levänen; Magnus Sköld; Elizabeth A. Thompson; Osama Saher; Otto K. Kari; Tatu Lajunen; Eva Sverremark Ekström; Caroline Nilsson; Yevheniia Ishchenko; Tarja Malm; Matthew J. A. Wood; Ultan F. Power; Sergej Masich; Anders Lindén; Johan K. Sandberg; Janne Lehtiö; Anna-Lena Spetz; Samir EL Andaloussi

Nature Communications · 2019

© The Author(s) 2019https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/501100003748Svenska Sällskapet för Medicinsk Forskning (Swedish Society for Medical Research)https://doi.org/10.13039/501100004359Vetenskapsrådet (Swedish Research Council)

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T18:33:37.371860+00:00

DOI: 10.1038/s41467-019-10192-2 · PMC6536551